University of Southern California: Colorectal Neoplasms trials
The registry lists 29 Colorectal Neoplasms studies with University of Southern California as lead sponsor. 3 are open to participants now and 3 have results posted.
Phase 1 9Phase 2 10Phase 3 1No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal CancerRecruitingNCT06336902Phase 1
- Confronting Cancer as a CommunityRecruitingNCT06063928Not applicable
- Personalized Health Self-Management Training for Colorectal Cancer SurvivorsRecruitingNCT05984589Not applicable
- Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal CancerActive, not recruitingNCT03657641Phase 1/2Results posted
- Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal CancerCompletedNCT00159484Phase 1/2Results posted
- Study of Oxaliplatin, Capecitabine and Bevacizumab as First Line Treatment for Patients With Advanced Colorectal CancerCompletedNCT00159432Phase 2Results posted
- Intraoperative Use of Oxygen Saturation Imaging to Assess Intestinal PerfusionActive, not recruitingNCT07587619Phase 1/2
- Community Genetic Navigation Engagement Specialists to Increase Knowledge About Colorectal Cancer Genetics in Hispanic/Latino/a CommunitiesActive, not recruitingNCT07276048Not applicable
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsActive, not recruitingNCT07259304
- CoGENES Randomized Controlled Trial (RCT)Active, not recruitingNCT07229443Not applicable
- Randomized Trial of Follow-up to Mailed FIT KitsCompletedNCT06805383Not applicable
- Additional Mailed FIT KitsCompletedNCT06805370Not applicable
- Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal CancerActive, not recruitingNCT04832763Not applicable
- Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma PatientsTerminatedNCT03594448
- Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal CancerWithdrawnNCT03576963Phase 1/2
- Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal CancersCompletedNCT03563651
- Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate CancerWithdrawnNCT03563352
- 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus PanitumumabTerminatedNCT03300609Phase 3
- Exercise Program During Chemotherapy in Metastatic Colorectal CancerTerminatedNCT03111823Not applicable
- Gut Microbiome in Fecal Samples From Patients With Metastatic Cancer Undergoing Chemotherapy or ImmunotherapyTerminatedNCT02960282
- High Definition Single Cell Analysis in Colorectal CancerCompletedNCT02809716
- Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal CancerWithdrawnNCT02413853Phase 2
- A Pilot Study of PPX in Women With Metastatic Colorectal CancerCompletedNCT00598247Phase 1
- Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal CancerCompletedNCT00336141Phase 1
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Study of Xeloda and Gleevec in Patients With Advanced Solid TumorsCompletedNCT00183833Phase 1
- Capecitabine and Gemcitabine in Patients With Metastatic Colorectal CancerCompletedNCT00159445Phase 2
- Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to LiverWithdrawnNCT00035919Phase 1/2
- Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00006037Phase 2